No Detail Found!

Novel Risk Factors for Coronary Heart Disease in Type II Diabetes Mellitus.

Author(s)
Sadaf Durrani Department of Biochemistry, Khyber Medical College, Peshawar, Pakistan
Ubaidur Rahman Department of Biochemistry, Khyber Medical College, Peshawar, Pakistan
Sobia Ali Department of Biochemistry, Khyber Medical College, Peshawar, Pakistan
Mudassir Ahmad Khan Department of Biochemistry, Khyber Medical College, Peshawar, Pakistan
Saifur Rahman Wazir Department of Biochemistry, Khyber Medical College, Peshawar, Pakistan
Abstract
Objective: To evaluate adiponectin, a novel biomarker, and other known cardiovascular risk factors in type 2 diabetic subjects belonging to Khyber Pakhtunkhwa. Material and Methods: This cross-sectional and analytical study was conducted in Bio-Chemistry Department Khyber Medical College, Peshawar, Pakistan from January 2016 to December 2016, the participants were randomly selected from the OPDs of three tertiary care hospitals of Peshawar. The study comprised of two groups. Group A contained 60 type 2 diabetic subjects having coronary heart disease and group B consisted of healthy control. Detailed history of all participants was recorded on a questionnaire including their blood pressure and body mass index. Fasting blood samples were collected and were analyzed for serum adiponectin level, glycosylated hemoglobin, fasting blood sugar and fasting lipid profile including cholesterol, triglycerides, low density lipoprotein, high density lipoprotein and very low density lipoprotein. Analysis of the data was done with Statistical Package for the Social Sciences, version 19. Results: Patients who had type 2 diabetes and coronary heart disease were found to have low adiponectin (3.2±1.1 vs. 11.7±2.6, P=<0.01) and high density lipoprotein (33.05±8.6 vs. 42.86±9.4, p=<0.01)) and significantly high levels of fasting blood glucose (198.1±106.7 vs. 90.5±15.7, p=<0.01), glycosylated hemoglobin (8.7±1.5 vs. 5.1±0.3, p=<0.01), total cholesterol (218.6±44.02 vs. 195.8±30.3), triglycerides (235.1±66.7 vs. 200.86±64.2) and low density lipoprotein (136.5±42.3 vs. 112.02±29.5). Moreover; they were mostly males and were of increased age group (60.6±9.7 vs. 46±5.3). All known risk factors of CHD such as use of tobacco, alcohol, physical inactivity, hypertension, genetic history of diabetes and coronary heart disease were present in higher percentage in diabetics having coronary heart disease than the healthy control group. Conclusion: Marked hypoadiponectinemia, and traditional risk factors such as poor glycemic control and dyslipidemia are present in diabetic subjects having coronary heart disease.
Publication Details
Page(s) 195-199
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 25, Issue: 2, Year: 2017

Request the full text from PASTIC

References
BittencourtC,PivetVM,OliveiraCSV,CrispimS,MeiraD,RosaPS, 2014.Association of classical risk factors and coronary artery disease in type 2 diabetic patients submitted to coronary angiography,Diabetol Metab Syndr 6 46 -48
TakemuraY,WalshK,OuchiN., 2007.Adiponectin and cardiovascular inflammatory responses,Current Atherosclerosis reports 9 238 -43
PistroschF,NataliA,HanefeldM., 2011.Is hyperglycemia a cardiovascular risk factor? Diabetes Care, 34 128 -31
AnietabasiSO,ChinyereAO,AnoustaCN,EdmundRE,JohnUE,AnthonyJU, 2013.Adiponectin and cardiovascular risk factors in relation with glycemic control in type 2 diabetics,Int J Res Med Sci 1 563 -70
OliveiraCSV,GiuffridaFMA,CrispimF,Saddi-RosaP,ReisAF, 2011.ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease,Arq Bras Endocrinol Metabol 55 446 -54
AdyaR,TanBK,RandevaHS, 2015.Differential effects of leptin and adiponectin in endothelial angiogenesis,J Diabetes Res 49 13 -21
LimS,QuonMJ,KohKK, 2014.Modulation of adiponectin as a potential therapeutic strategy,Atherosclerosis 233 721 -8
RobinsonK,PrinsJ,VenkateshB., 2011.Clinical review: Adiponectin biology and its role in inflammation and critical illness,Crit Care 15 221 -9
YamauchiT,IwabuM,Okada-IwabuM,KadowakT., .Adiponectin receptors: A review of their structure, function and how they work,Clin Endicrinol Metab. -
YamauchiT,KadowakiT., 2013.Adiponectin receptor as a key player in healthy longevity and obesity-related diseases,Cell Metabolism 17 185 -96
GhanbariAA,DorrR,SpitzerS,StumpfJ,BritzA,Amann-ZalanI, 2013.Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance,Diab Vasc Dis Res 10 452 -8
GelonezeB,PereiraJA,ParejaJC,LimaMM,LazarinMA,SouzaIC, 2009.Overcoming metabolic syndrome in severe obesity: Adiponectin as a marker of insulin sensitivity and HDLcholesterol improvements after gastric bypass,Arq Bras Endocrinol Metabol 53 293 -300
FriedwaldWT,LevyPI,FredricksonDS, 1972.Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuge,Clin Chem 18 449 -502
DelongDM,DelongER,WoodPD,LippetK,Rifkind BM, 1986.A comparison of methods for the estimation of plasma low and very low density lipoprotein cholesterol,J Am Med Assoc 256 2372 -77
MohanV,DeepaR,PradeepaR,SanthanakrishnanV,MohanA,VelmuruganK, 2005.Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CRUES-4), 54 476 -81
YuJG,JavorschiS,HevenerAL,KruszynskaYT,NormanRA,SinhaM, 2002.The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects,Diabetes 51 2968 -74
SchnabelR,MessowCM,LubosE,Espinola-KleinC,RupprechtHJ,BickelC, 2008.Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study,Eur Heart J 29 649 -57
SattarN,WannametheeG,SarwarN,TchernovaJ,CherryL,WallaceAM, 2006.Adiponectin and coronary heart disease: a prospective study and meta-analysis,Circulation 114 623 -29
RasulS,IihanA,ReiterMH,Baumgartner-ParzerS, 2011.Kautzky-willer A. Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients,Gender Medicine 8 93 -102
ZoccaliC,MallamaciF,TripepiG,BenedettoFA,CutrupiS,ParlongoS, 2002.Adiponectin, metabolic factors, and cardiovascular events among patients with end-stage renal disease,J Am Soc Nephrol 13 134 -41
SchulzeMB,ShaiI,RimmEB,LiT,RifaiN,HuBF, 2005.Adiponectin and future coronary heart disease events among men with type 2 diabetes,Diabetes 54 534 -39
AliM,OtokozawaS,AsztalosBF,WhiteCC,Demissie BanjawS,CupplesLA, .Adiponectin: an independent risk factor for coronary heart disease in men, -
PischonT,HuFB,GirmanCJ,RifaiN,MansonJE,RexrodeKM, 2011.Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women,Atherosclerosis 219 322 -29
ObataY,YamadaY,KyoM,TakahiY,SaishoK,TambaS, 2013.Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes,J Diabetes Invest 4 475 -82
KarastergiouK,Mohamed-AliV,JehangiriM,KaskiJ, 2009.Adiponectin for prediction of cardiovascular risk?,Br J Diabe Vascu Dis 9 150 -54
AliMK,NarayanKMV,TandonN.,Diabetes, 2010.& coronary heart disease: Current perspectives,Indian J Med Res 132 584 -97
NayakSB,MaharajN, 2012.Association between altered lipid profile, body mass index, low plasma adiponectin and varied blood pressure in Trinidad type 2 diabetic and non-diabetic subjects,J Med Sci 65 214 -21
YamamotoS,MatsushitaY,NakagawaT,HayashiT,NodaM,MizoueT., 2014.Circulating adiponectin levels and risk of type 2 diabetes in the Japanese,Nutr Diabetes 4 130 -35
TabakAG,BrunnerEJ,MillerMA,KaranamS,McTernanPG,CappuccinoFP, 2009.Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids and inflammation-Whitehall II study,Horm Met Res 41 626 -29
MatsushitaY,NakagawaT,YamamotaS,KatoT,OuchiT, 2014.Adiponectin and visceral fat associate with cardiovascular risk factors,Obesity 21 287 -91
LuoM,Oza-FrankR,NarayanKMV,GokulakrishnanK,MohanV, 2010.Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males,J Diab Sci Tech 4 645 -50
IzadiV,FarabadE,AzadbakhtL, 2013.Epidemiological evidence on serum adiponectin level and lipid profile,Int Prev Med 4 133 -40
WingRR,ReboussinD,LewisCE, 2013.Intensive lifestyle intervention in type 2 diabetes,N Engl J Med 369 145 -54
BorgesMC,LawlorDA,OliveiraCD,WhiteJ,HortaBL,BarrosAJD, 2016.Role of adiponectin in coronary heart disease risk,Circ Res 119 491 -99
LawlorDA,SmithGD,EbrahimS,ThompsonC,Sattar N, 2005.Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women,J Clin Endocrinol Metab 90 5677 -83
LindsayRS,ResnickHE,ZhuJ,TunML,HowardBV,ZhangY, 2005.Adiponectin and coronary heart disease: the strong heart study,Atheroscler Thromb Vascu Biol 25 115 -16
0

Citations

0

Downloads

48

Views